Home / Import refusals / 112-7305844-0/1/1

FDA Import Refusal 112-7305844-0/1/1 — Halo Pharmaceutical Canada Inc

Halo Pharmaceutical Canada Inc — FEI 3009856628

The FDA refused shipment 112-7305844-0/1/1 from Halo Pharmaceutical Canada Inc (Canada) on August 5, 2011. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 3 other import refusals on record.

Refusal Details

Date
August 5, 2011
Country
Canada
Product Category
Drugs and Biologics
Product Code
61JDB08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Recent inspections

  • 1202435 (NAI Fri Feb 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030363 (NAI Fri Sep 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 949035 (NAI Thu Nov 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903523 (VAI Fri Nov 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • 113-7841397-2/11/1 (Mon Oct 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-7305844-0/1/2 (Fri Aug 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 112-1158381-3/1/1 (Thu Jan 24 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources